Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

TCT 2015: Polymer-Free DES From Medtronic And Biosensors Show Early Promise

This article was originally published in Clinica

Executive Summary

Preliminary results from the RevElution trial of Medtronic’s Drug-Filled Stent (DFS) suggest this polymerless metal drug eluting stent may overcome the limitations of current metal and bioabsorbable drug-eluting coronary stents, according to the trial’s co-principal investigator Stephen Worthley of the Royal Adelaide Hospital in Australia.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register